Tamoxifen use for the management of mania: A review of current preclinical evidence

Psychopharmacology

Volumn 231, Issue 4, 2014, Pages 639-649

  Armani, Fernanda ^a   Andersen, Monica Levy ^a   Galduróz, José Carlos Fernandes ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Rua Botucatu   (Brazil)

Author keywords

Animal models; Antimanic treatment; Bipolar disorder; Mania; Protein kinase C (PKC); Tamoxifen

Indexed keywords

ANIMALS; ANTIMANIC AGENTS; BIPOLAR DISORDER; DISEASE MODELS, ANIMAL; HUMANS; PROTEIN KINASE C; TAMOXIFEN;

EID: 84893926524     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-013-3397-x     Document Type: Review

References (151)

1. Abrial E, Etievant A, Bétry C, Scarna H, Lucas G, Haddjeri N, Lambás-Señas L (2012) Protein kinase C regulates mood-related behaviors and adult hippocampal cell proliferation in rats. Prog Neuropsychopharmacol Biol Psychiatry 43C:40-48
2. Aksoy E, Goldman M, Willems F (2004) Protein kinase C epsilon: a new target to control inflammation and immune-mediated disorders. Int J Biochem Cell Biol 36:183-8
3. Alda M, Hajek T, Calkin C, O'Donovan C (2009) Treatment of bipolar disorder: new perspectives. Ann Med 41:186-96
4. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Washington, DC
5. Amrollahi Z, Rezaei F, Salehi B, Modabbernia AH, Maroufi A, Esfandiari GR, Naderi M, Ghebleh F, Ahmadi-Abhari SA, Sadeghi M, Tabrizi M, Akhondzadeh S (2011) Double-blind, randomized, placebo-controlled 6-week study on the efficacy and safety of the tamoxifen adjunctive to lithium in acute bipolar mania. J Affect Disord 129:327-31
6. Andreatini R (2002) A importância dos modelos animais em psiquiatria. Rev Bras Psiquiatr 24:164
7. Andreatini R, Lacerda R, Vital M (2006) Modelos animais em psicofarmacologia. In: Almeida R (ed) Psicofarmacologia: fundamentos práticos. Guanabara-Koogan, Rio de Janeiro, pp 53-61
8. Armani F, Andersen ML, Andreatini R, Frussa-Filho R, Tufik S, Galduróz JC (2012) Successful combined therapy with tamoxifen and lithium in a paradoxical sleep deprivation-induced mania model. CNS Neurosci Ther 18:119-25
9. Barbini B, Bertelli S, Colombo C, Smeraldi E (1996) Sleep loss, a possible factor in augmenting manic episode. Psychiatry Res 65:121-5
10. Basu A, Pal D (2010) Two faces of protein kinase Cδ: the contrasting roles of PKCδ in cell survival and cell death. Sci World J 10:2272-84
11. Baum AE, Akula N, Cabanero M, Cardona I, Corona W, Klemens B, Schulze TG, Cichon S, Rietschel M, Nothen MM, Georgi A, Schumacher J, Schwarz M, Abou Jamra R, Hofels S, Propping P, Satagopan J, Detera-Wadleigh SD, Hardy J, McMahon FJ (2008) A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 13:197-207
12. Bebchuk JM, Arfken CL, Dolan-Manji S, Murphy J, Hasanat K, Manji HK (2000) A preliminary investigation of a protein kinase C inhibitor in the treatment of acute mania. Arch Gen Psychiatry 57:95-7
13. Becker JB, Snyder PJ, Miller MM, Westgate SA, Jenuwine MJ (1987) The influence of estrous cycle and intrastriatal estradiol on sensorimotor performance in the female rat. Pharmacol Biochem Behav 27:53-9
14. Benedetti F, Fresi F, Maccioni P, Smeraldi E (2008) Behavioural sensitization to repeated sleep deprivation in a mice model of mania. Behav Brain Res 187:221-7
15. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS (1998) A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol Psychiatry 44:88-97
16. Birnbaum SG, Yuan PX, Wang M, Vijayraghavan S, Bloom AK, Davis DJ, Gobeske KT, Sweatt JD, Manji HK, Arnsten AF (2004) Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science 306:882-4
17. Bitran JA, Potter WZ, Manji HK, Gusovsky F (1990) Chronic Li+ attenuates agonist- and phorbol ester-mediated Na+/H+ antiporter activity in HL-60 cells. Eur J Pharmacol 188:193-202
18. Browman KE, Kantor L, Richardson S, Badiani A, Robinson TE, Gnegy ME (1998) Injection of the protein kinase C inhibitor Ro31-8220 into the nucleus accumbens attenuates the acute response to amphetamine: tissue and behavioral studies. Brain Res 814:112-9
19. Burdick KE, Braga RJ, Goldberg JF, Malhotra AK (2007) Cognitive dysfunction in bipolar disorder: future place of pharmacotherapy. CNS Drugs 21:971-81
20. Burguillos MA, Deierborg T, Kavanagh E, Persson A, Hajji N, Garcia-Quintanilla A, Cano J, Brundin P, Englund E, Venero JL, Joseph B (2011) Caspase signalling controls microglia activation and neurotoxicity. Nature 472:319-24
21. Burrows KB, Gudelsky G, Yamamoto BK (2000) Rapid and transient inhibition of mitochondrial function following methamphetamine or 3,4- methylenedioxymethamphetamine administration. Eur J Pharmacol 398:11-8
22. Cadet JL, Jayanthi S, Deng X (2005) Methamphetamine-induced neuronal apoptosis involves the activation of multiple death pathways. Review. Neurotox Res 8:199-206
23. Calabrese B, Halpain S (2005) Essential role for the PKC target MARCKS in maintaining dendritic spine morphology. Neuron 48:77-90
24. Cardoso CM, Almeida LM, Custódio JB (2002) 4-Hydroxytamoxifen is a potent inhibitor of the mitochondrial permeability transition. Mitochondrion 1:485-95
25. Cardoso CM, Almeida LM, Custódio JB (2004) Protection of tamoxifen against oxidation of mitochondrial thiols and NAD(P)H underlying the permeability transition induced by prooxidants. Chem Biol Interact 148:149-61
26. Casabona G (1997) Intracellular signal modulation: a pivotal role for protein kinase C. Prog Neuro-Psychopharmacol Biol Psychiatry 21:407-25
27. Cechinel-Recco K, Valvassori SS, Varela RB, Resende WR, Arent CO, Vitto MF, Luz G, de Souza CT, Quevedo J (2012) Lithium and tamoxifen modulate cellular plasticity cascades in animal model of mania. J Psychopharmacol 26:1594-604
28. Cervo L, Mukherjee S, Bertaglia A, Samanin R (1997) Protein kinases A and C are involved in the mechanisms underlying consolidation of cocaine place conditioning. Brain Res 775:30-6
29. Chen G, Manji HK, Hawver DB, Wright CB, Potter WZ (1994) Chronic sodium valproate selectively decreases protein kinase C alpha and epsilon in vitro. J Neurochem 63:2361-4
30. Chen L, Hahn H, Wu G, Chen CH, Liron T, Schechtman D, Cavallaro G, Banci L, Guo Y, Bolli R, Dorn GW, Mochly-Rosen D (2001) Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A 98:11114-9
31. Churchill E, Budas G, Vallentin A, Koyanagi T, Mochly-Rosen D (2008) PKC isozymes in chronic cardiac disease: possible therapeutic targets? Annu Rev Pharmacol Toxicol 48:569-99
32. Colombo C, Benedetti F, Barbini B, Campori E, Smeraldi E (1999) Rate of switch from depression into mania after therapeutic sleep deprivation in bipolar depression. Psychiatry Res 86:267-70
33. Couldwell WT, Hinton DR, Surnock AA, DeGiorgio CM, Weiner LP, Apuzzo ML, Masri L, Law RE, Weiss MH (1996) Treatment of recurrent malignant gliomas with chronic oral high-dose tamoxifen. Clin Cancer Res 2:619-22
34. Craske ML, Fivaz M, Batada NN, Meyer T (2005) Spines and neurite branches function as geometric attractors that enhance protein kinase C action. J Cell Biol 170:1147-58
35. Das Evcimen N, King GL (2007) The role of protein kinase C activation and the vascular complications of diabetes. Pharmacol Res 55:498-510
36. Dempsey EC, Cool CD, Littler CM (2007) Lung disease and PKCs. Pharmacol Res 55:545-59
37. Dencker D, Husum H (2010) Antimanic efficacy of retigabine in a proposed mouse model of bipolar disorder. Behav Brain Res 207:78-83
38. Deng Y, Kohlwein SD, Mannella CA (2002) Fasting induces cyanide-resistant respiration and oxidative stress in the amoeba Chaos carolinensis: implications for the cubic structural transition in mitochondrial membranes. Protoplasma 219:160-7
39. DiazGranados N, Zarate CA Jr (2008) A review of the preclinical and clinical evidence for protein kinase C as a target for drug development for bipolar disorder. Curr Psychiatry Rep 10:510-9
40. Einat H (2006) Modelling facets of mania - new directions related to the notion of endophenotypes. J Psychopharmacol 20:714-22
41. Einat H (2007a) Different behaviors and different strains: potential new ways to model bipolar disorder. Neurosci Biobehav Rev 31:850-7
42. Einat H (2007b) Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease. Behav Genet 37:244-55
43. Einat H, Chen G, Manji H (2004) Possible involvement of protein kinase C in the pathophysiology and treatment of bipolar disorder. Harefuah 143(420-5):462
44. Einat H, Yuan P, Szabo ST, Dogra S, Manji HK (2007) Protein kinase C inhibition by tamoxifen antagonizes manic-like behavior in rats: implications for the development of novel therapeutics for bipolar disorder. Neuropsychobiology 55:123-31
45. Ferreira JC, Koyanagi T, Palaniyandi SS, Fajardo G, Churchill EN, Budas G, Disatnik MH, Bernstein D, Brum PC, Mochly-Rosen D (2011) Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy. J Mol Cell Cardiol 51:980-7
46. Fibiger HC (1995) Neurobiology of depression: focus on dopamine. In: Gessa GL, Fratta W, Pani L, Serra G (eds) Depression and mania: from neurobiology to treatment. Raven, New York, pp 1-18
47. Flaisher-Grinberg S, Overgaard S, Einat H (2009) Attenuation of high sweet solution preference by mood stabilizers: a possible mouse model for the increased reward-seeking domain of mania. J Neurosci Methods 177:44-50
48. Frey BN, Valvassori SS, Reus GZ, Martins MR, Petronilho FC, Bardini K, Dal-Pizzol F, Kapczinski F, Quevedo J (2006) Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 31:326-32
49. Friedman E, Hoau Yan W, Levinson D, Connell TA, Singh H (1993) Altered platelet protein kinase C activity in bipolar affective disorder, manic episode. Biol Psychiatry 33:520-5
50. Garrido JL, Godoy JA, Alvarez A, Bronfman M, Inestrosa NC (2002) Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway. FASEB J 16:1982-4
51. Geraldes P, King GL (2010) Activation of protein kinase C isoforms and its impact on diabetic complications. Circ Res 106:1319-31
52. Gessa GL, Pani L, Fadda P, Fratta W (1995) Sleep deprivation in the rat: an animal model of mania. Eur Neuropsychopharmacol 5(Suppl):89-93
53. Geyer MA (2008) Developing translational animal models for symptoms of schizophrenia or bipolar mania. Neurotox Res 14:71-8
54. Giambalvo CT (1992a) Protein kinase C and dopamine transport - 1. Effects of amphetamine in vivo. Neuropharmacology 31:1201-10
55. Giambalvo CT (1992b) Protein kinase C and dopamine transport - 2. Effects of amphetamine in vitro. Neuropharmacology 31:1211-22
56. Gitlin M (2006) Treatment-resistant bipolar disorder. Mol Psychiatry 11:227-40
57. Gnegy ME, Hong P, Ferrell ST (1993) Phosphorylation of neuromodulin in rat striatum after acute and repeated, intermittent amphetamine. Brain Res Mol Brain Res 20:289-98
58. Goodwin FK, Jamison KR (2007) Manic-depressive illness: bipolar disorders and recurrent depression, 2nd edn. Oxford University Press, London
59. Gould TD, Einat H (2007) Animal models of bipolar disorder and mood stabilizer efficacy: a critical need for improvement. Neurosci Biobehav Rev 31:825-31
60. Hahn CG, Friedman E (1999) Abnormalities in protein kinase C signaling and the pathophysiology of bipolar disorder. Bipolar Disord 1:81-6
61. Huang KP (1990) Role of protein kinase C in cellular regulation. Biofactors 2:171-8
62. Inagaki K, Churchill E, Mochly-Rosen D (2006) Epsilon protein kinase C as a potential therapeutic target for the ischemic heart. Cardiovasc Res 70:222-30
63. Jordan VC (1992) The role of tamoxifen in the treatment and prevention of breast cancer. Curr Probl Cancer 16:129-76
64. Jordan VC (2003) Tamoxifen: a most unlikely pioneering medicine. Nat Rev Drug Discov 2:205-13
65. Kantor L, Gnegy ME (1998) Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices. J Pharmacol Exp Ther 284:592-8
66. Kara NZ, Einat H (2013) Rodent models for mania: practical approaches. Cell Tissue Res 354:191-201
67. Karn A, Jha AK, Shrestha S, Acharya B, Poudel S, Bhandari RB (2010) Tamoxifen for breast cancer. JNMA J Nepal Med Assoc 49:62-7
68. Kato T (2008) Molecular neurobiology of bipolar disorder: a disease of 'mood-stabilizing neurons'?. Trends Neurosci 31:495-503
69. Kimelberg HK, Feustel PJ, Jin Y, Paquette J, Boulos A, Keller RW, Tranmer BI (2000) Acute treatment with tamoxifen reduces ischemic damage following middle cerebral artery occlusion. Neuroreport 11:2675-9
70. Krishnan KR (2005) Psychiatric and medical comorbidities of bipolar disorder. Psychosom Med 67:1-8
71. Kulkarni J, Garland KA, Scaffidi A, Headey B, Anderson R, de Castella A, Fitzgerald P, Davis SR (2006) A pilot study of hormone modulation as a new treatment for mania in women with bipolar affective disorder. Psychoneuroendocrinology 31:543-7
72. Kuloglu M, Ustundag B, Atmaca M, Canatan H, Tezcan AE, Cinkilinc N (2002) Lipid peroxidation and antioxidant enzyme levels in patients with schizophrenia and bipolar disorder. Cell Biochem Funct 20:171-5
73. Kupfer DJ (2005) The increasing medical burden in bipolar disorder. Jama 293:2528-30
74. Kurita M, Nishino S, Ohtomo K, Rai M, Shirakawa H, Mashiko H, Niwa S, Nakahata N (2007) Sodium valproate at therapeutic concentrations changes Ca2+ response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells. Prog Neuropsychopharmacol Biol Psychiatry 31:600-4
75. Kuruvilla A, Uretsky NJ (1981) Effect of sodium valproate on motor function regulated by the activation of GABA receptors. Psychopharmacol (Berl) 72:167-72
76. Lenox RH, Watson DG, Patel J, Ellis J (1992) Chronic lithium administration alters a prominent PKC substrate in rat hippocampus. Brain Res 570:333-40
77. Lerer B, Globus M, Brik E, Hamburger R, Belmaker RH (1984) Effect of treatment and withdrawal from chronic lithium in rats on stimulant-induced responses. Neuropsychobiology 11:28-32
78. MacDonald JF, Kotecha SA, Lu WY, Jackson MF (2001) Convergence of PKC-dependent kinase signal cascades on NMDA receptors. Curr Drug Targets 2:299-312
79. Machado-Vieira R, Kapczinski F, Soares JC (2004) Perspectives for the development of animal models of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 28:209-24
80. Machado-Vieira R, Salvadore G, DiazGranados N, Ibrahim L, Latov D, Wheeler-Castillo C, Baumann J, Henter ID, Zarate CA (2010) New therapeutic targets for mood disorders. Sci World J 10:713-26
81. Mackay HJ, Twelves CJ (2007) Targeting the protein kinase C family: are we there yet? Nat Rev Cancer 7:554-62
82. Maioli E, Valacchi G (2010) Rottlerin: bases for a possible usage in psoriasis. Curr Drug Metab 11:425-30
83. Malkesman O, Austin DR, Chen G, Manji HK (2009) Reverse translational strategies for developing animal models of bipolar disorder. Dis Model Mech 2:238-45
84. Mamelak M (1978) An amphetamine model of manic depressive illness. Int Pharmacopsychiatry 13:193-208
85. Manji HK, Bersudsky Y, Chen G, Belmaker RH, Potter WZ (1996) Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol. Neuropsychopharmacol 15:370-81
86. Manji H (2008) The role of synaptic and cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Actas Esp Psiquiatr 36(Suppl 1):1-2
87. Manji HK, Lenox RH (2000) Signaling: cellular insights into the pathophysiology of bipolar disorder. Biol Psychiatry 48:518-30
88. Manji HK, Etcheberrigaray R, Chen G, Olds JL (1993) Lithium decreases membrane-associated protein kinase C in hippocampus: selectivity for the alpha isozyme. J Neurochem 61:2303-10
89. Mastronardi L, Puzzilli F, Couldwell WT, Farah JO, Lunardi P (1998) Tamoxifen and carboplatin combinational treatment of high-grade gliomas. Results of a clinical trial on newly diagnosed patients. J Neurooncol 38:59-68
90. Meinhard N, Kessing LV, Vinberg M (2013) The role of estrogen in bipolar disorder, a review. Nord J Psychiatry.
91. Mellor H, Parker PJ (1998) The extended protein kinase C superfamily. Biochem J 332(Pt 2):281-92
92. Mochly-Rosen D, Das K, Grimes KV (2012) Protein kinase C, an elusive therapeutic target? Nat Rev Drug Discov 11:937-57
93. Moretti M, Valvassori SS, Steckert AV, Rochi N, Benedet J, Scaini G, Kapczinski F, Streck EL, Zugno AI, Quevedo J (2011) Tamoxifen effects on respiratory chain complexes and creatine kinase activities in an animal model of mania. Pharmacol Biochem Behav 98:304-10
94. Morgan MA, Pfaff DW (2001) Effects of estrogen on activity and fear-related behaviors in mice. Horm Behav 40:472-82
95. Morgan MA, Pfaff DW (2002) Estrogen's effects on activity, anxiety, and fear in two mouse strains. Behav Brain Res 132:85-93
96. Morgan MA, Schulkin J, Pfaff DW (2004) Estrogens and non-reproductive behaviors related to activity and fear. Neurosci Biobehav Rev 28:55-63
97. Murriel CL, Mochly-Rosen D (2003) Opposing roles of delta and epsilonPKC in cardiac ischemia and reperfusion: targeting the apoptotic machinery. Arch Biochem Biophys 420:246-54
98. Nestler EJ, Hyman SE (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13:1161-9
99. Newton AC (1995) Protein kinase C. Seeing two domains. Curr Biol 5:973-6
100. Nierenberg AA (2010) A critical appraisal of treatments for bipolar disorder. Prim Care Companion J Clin Psychiatry 12:23-9
101. Nishizuka Y (1992) Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-14
102. Nishizuka Y, Nakamura S (1995) Lipid mediators and protein kinase C for intracellular signalling. Clin Exp Pharmacol Physiol Suppl 22:S202-3
103. Nogues X (1997) Protein kinase C, learning and memory: a circular determinism between physiology and behaviour. Progress Neuro-psychopharmacol Biol Psychiatry 21:507-29
104. Obata T (2006) Tamoxifen protect against hydroxyl radical generation induced by phenelzine in rat striatum. Toxicology 222:46-52
105. Ohno S, Kawasaki H, Imajoh S, Suzuki K, Inagaki M, Yokokura H, Sakoh T, Hidaka H (1987) Tissue-specific expression of three distinct types of rabbit protein kinase C. Nature 325:161-6
106. Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O (2004) Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 19:89-95
107. Pandey GN, Ren X, Dwivedi Y, Pavuluri MN (2008) Decreased protein kinase C (PKC) in platelets of pediatric bipolar patients: effect of treatment with mood stabilizing drugs. J Psychiatr Res 42:106-16
108. Peet M, Peters S (1995) Drug-induced mania. Drug Saf 12:146-53
109. Pereira M, Martynhak BJ, Baretta IP, Correia D, Siba IP, Andreatini R (2011) Antimanic-like effect of tamoxifen is not reproduced by acute or chronic administration of medroxyprogesterone or clomiphene. Neurosci Lett 500:95-8
110. Perry W, Minassian A, Paulus MP, Young JW, Kincaid MJ, Ferguson EJ, Henry BL, Zhuang X, Masten VL, Sharp RF, Geyer MA (2009) A reverse-translational study of dysfunctional exploration in psychiatric disorders: from mice to men. Arch Gen Psychiatry 66:1072-80
111. Perry W, Minassian A, Henry B, Kincaid M, Young JW, Geyer MA (2010) Quantifying over-activity in bipolar and schizophrenia patients in a human open field paradigm. Psychiatry Res 178:84-91
112. Pollack IF, DaRosso RC, Robertson PL, Jakacki RL, Mirro JR Jr, Blatt J, Nicholson S, Packer RJ, Allen JC, Cisneros A, Jordan VC (1997) A phase I study of high-dose tamoxifen for the treatment of refractory malignant gliomas of childhood. Clin Cancer Res 3:1109-15
113. Post RM, Weiss SR (1989) Sensitization, kindling, and anticonvulsants in mania. J Clin Psychiatry 50(Suppl):23-30, discussion 45-7
114. Rajkowska G (2002) Cell pathology in bipolar disorder. Bipolar Disord 4:105-16
115. Ramakers GM, Pasinelli P, Hens JJ, Gispen WH, De Graan PN (1997) Protein kinase C in synaptic plasticity: changes in the in situ phosphorylation state of identified pre- and postsynaptic substrates. Prog Neuropsychopharmacol Biol Psychiatry 21:455-86
116. Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV, Debsikdar VB, Mahadik SP (2003) Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 121:109-22
117. Sabioni P, Baretta IP, Ninomiya EM, Gustafson L, Rodrigues AL, Andreatini R (2008) The antimanic-like effect of tamoxifen: behavioural comparison with other PKC-inhibiting and antiestrogenic drugs. Prog Neuropsychopharmacol Biol Psychiatry 32:1927-31
118. Schloesser RJ, Huang J, Klein PS, Manji HK (2007) Cellular Plasticity Cascades in the Pathophysiology and Treatment of Bipolar Disorder. Neuropsychopharmacology 33:110-133
119. Shaldubina A, Einat H, Szechtman H, Shimon H, Belmaker RH (2002) Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder. J Neural Transm 109:433-40
120. Smith DF (1981) Central and peripheral effects of lithium on amphetamine-induced hyperactivity in rats. Pharmacol Biochem Behav 14:439-42
121. Smith LA, Cornelius V, Warnock A, Tacchi MJ, Taylor D (2007) Pharmacological interventions for acute bipolar mania: a systematic review of randomized placebo-controlled trials. Bipolar Disord 9:551-60
122. Soares JC, Chen G, Dippold CS, Wells KF, Frank E, Kupfer DJ, Manji HK, Mallinger AG (2000) Concurrent measures of protein kinase C and phosphoinositides in lithium-treated bipolar patients and healthy individuals: a preliminary study. Psychiatry Res 95:109-18
123. Stabel S, Parker PJ (1991) Protein kinase C. Pharmacol Ther 51:71-95
124. Steckert AV, Valvassori SS, Mina F, Lopes-Borges J, Varela RB, Kapczinski F, Dal-Pizzol F, Quevedo J (2012) Protein kinase C and oxidative stress in an animal model of mania. Curr Neurovasc Res 9:47-57
125. Steketee JD (1993) Injection of the protein kinase inhibitor H7 into the A10 dopamine region blocks the acute responses to cocaine: behavioral and in vivo microdialysis studies. Neuropharmacology 32:1289-97
126. Steketee JD (1994) Intra-A10 injection of H7 blocks the development of sensitization to cocaine. Neuroreport 6:69-72
127. Steketee JD (1997) Intra-ventral tegmental area administration of H7 delays, but does not prevent the development of cocaine-induced sensitization. Brain Res Bull 43:565-71
128. Szabo ST, Machado-Vieira R, Yuan P, Wang Y, Wei Y, Falke C, Cirelli C, Tononi G, Manji HK, Du J (2009) Glutamate receptors as targets of protein kinase C in the pathophysiology and treatment of animal models of mania. Neuropharmacology 56:47-55
129. Tanaka C, Nishizuka Y (1994) The protein kinase C family for neuronal signaling. Ann Rev Neurosci 17:551-67
130. Tang P, Roldan G, Brasher PM, Fulton D, Roa W, Murtha A, Cairncross JG, Forsyth PA (2006) A phase II study of carboplatin and chronic high-dose tamoxifen in patients with recurrent malignant glioma. J Neurooncol 78:311-6
131. Torres IJ, DeFreitas VG, DeFreitas CM, Kauer-Sant'Anna M, Bond DJ, Honer WG, Lam RW, Yatham LN (2010) Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. J Clin Psychiatry 71:1234-42
132. Totoń E, Ignatowicz E, Skrzeczkowska K, Rybczyńska M (2011) Protein kinase Cε as a cancer marker and target for anticancer therapy. Pharmacol Rep 63:19-29
133. Tuquet C, Dupont J, Mesneau A, Roussaux J (2000) Effects of tamoxifen on the electron transport chain of isolated rat liver mitochondria. Cell Biol Toxicol 16:207-19
134. Wade GN (1972) Gonadal hormones and behavioral regulation of body weight. Physiol Behav 8:523-34
135. Walf AA, Frye CA (2006) A review and update of mechanisms of estrogen in the hippocampus and amygdala for anxiety and depression behavior. Neuropsychopharmacology 31:1097-111
136. Wang HY, Friedman E (1989) Lithium inhibition of protein kinase C activation-induced serotonin release. Psychopharmacol (Berl) 99:213-8
137. Wang HY, Friedman E (1996) Enhanced protein kinase C activity and translocation in bipolar affective disorder brains. Biol Psychiatry 40:568-75
138. Wang HY, Markowitz P, Levinson D, Undie AS, Friedman E (1999) Increased membrane-associated protein kinase C activity and translocation in blood platelets from bipolar affective disorder patients. J Psychiatr Res 33:171-9
139. Wang H, Friedman E (2001) Increased association of brain protein kinase C with the receptor for activated C kinase-1 (RACK1) in bipolar affective disorder. Biol Psychiatry 50:364-70
140. Watson DG, Lenox RH (1996) Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: potentiation by muscarinic receptor activation. J Neurochem 67:767-77
141. Wehr TA (1991) Sleep-loss as a possible mediator of diverse causes of mania. Br J Psychiatry 159:576-8
142. Wehr TA, Goodwin FK, Wirz-Justice A, Breitmaier J, Craig C (1982) 48-hour sleep-wake cycles in manic-depressive illness: naturalistic observations and sleep deprivation experiments. Arch Gen Psychiatry 39:559-65
143. Wehr TA, Sack DA, Rosenthal NE (1987) Sleep reduction as a final common pathway in the genesis of mania. Am J Psychiatry 144:201-4
144. Wu-Zhang AX, Newton AC (2013) Protein kinase C pharmacology: refining the toolbox. Biochem J 452:195-209
145. Yildiz A, Guleryuz S, Ankerst DP, Ongur D, Renshaw PF (2008) Protein kinase C inhibition in the treatment of mania: a double-blind, placebo-controlled trial of tamoxifen. Arch Gen Psychiatry 65:255-63
146. Young JW, Henry BL, Geyer MA (2011) Predictive animal models of mania: hits, misses and future directions. Br J Pharmacol 164:1263-84
147. Zanin-Zhorov A, Dustin ML, Blazar BR (2011) PKC-θ function at the immunological synapse: prospects for therapeutic targeting. Trends Immunol 32:358-63
148. Zarate CA, Manji HK (2009) Protein kinase C inhibitors: rationale for use and potential in the treatment of bipolar disorder. CNS Drugs 23:569-82
149. Zarate CA Jr, Singh JB, Carlson PJ, Quiroz J, Jolkovsky L, Luckenbaugh DA, Manji HK (2007) Efficacy of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania: a pilot study. Bipolar Disord 9:561-70
150. Zhang D, Anantharam V, Kanthasamy A, Kanthasamy AG (2007) Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease. J Pharmacol Exp Ther 322:913-22
151. Zhao Y, Wang LM, Chaiswing L, Yen HC, Oberley TD, Lien YC, Lin SM, Mattson MP, St Clair D (2006) Tamoxifen protects against acute tumor necrosis factor alpha-induced cardiac injury via improving mitochondrial functions. Free Radic Biol Med 40:1234-41